PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365A909. A total of 4 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107 | +167.5% | 65,000 | +218.6% | 0.00% | – |
Q2 2023 | $40 | -95.9% | 20,400 | -95.7% | 0.00% | -100.0% |
Q1 2023 | $985 | +114.6% | 469,500 | +39.9% | 0.00% | – |
Q4 2022 | $459 | -99.8% | 335,700 | +44.0% | 0.00% | – |
Q3 2022 | $242,000 | -38.6% | 233,100 | -35.6% | 0.00% | – |
Q2 2022 | $394,000 | +58.2% | 362,200 | +53.6% | 0.00% | – |
Q1 2022 | $249,000 | +369.8% | 235,800 | +267.3% | 0.00% | – |
Q4 2021 | $53,000 | -90.2% | 64,200 | -77.9% | 0.00% | -100.0% |
Q3 2021 | $543,000 | -2.3% | 290,800 | -0.1% | 0.00% | 0.0% |
Q2 2021 | $556,000 | +2317.4% | 291,100 | +559707.7% | 0.00% | – |
Q1 2021 | $23,000 | -84.0% | 52 | -87.0% | 0.00% | – |
Q4 2020 | $144,000 | +14300.0% | 399 | +7880.0% | 0.00% | – |
Q3 2020 | $1,000 | -98.6% | 5 | -97.4% | 0.00% | – |
Q2 2020 | $71,000 | +1083.3% | 189 | +575.0% | 0.00% | – |
Q1 2020 | $6,000 | -33.3% | 28 | -3.4% | 0.00% | – |
Q4 2019 | $9,000 | – | 29 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 56,000 | $61,000 | 0.00% |
GROUP ONE TRADING, L.P. | 634,600 | $692,000 | 0.00% |
SIMPLEX TRADING, LLC | 362,200 | $394,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |